elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26775134-4340B69A-C90C-4CF0-BDCF-17A04E3CDEBF
Q26775134-4340B69A-C90C-4CF0-BDCF-17A04E3CDEBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775134-4340B69A-C90C-4CF0-BDCF-17A04E3CDEBF
Profile of nintedanib in the treatment of solid tumors: the evidence to date
P2860
Q26775134-4340B69A-C90C-4CF0-BDCF-17A04E3CDEBF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775134-4340B69A-C90C-4CF0-BDCF-17A04E3CDEBF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8d150da4d65e9b46ef8562339aba47c52f49f835
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer